ID   SNRK_HUMAN              Reviewed;         765 AA.
AC   Q9NRH2; B2RAV6; Q14706; Q68D15; Q6IQ46; Q9NXI7;
DT   07-MAR-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   12-OCT-2022, entry version 176.
DE   RecName: Full=SNF-related serine/threonine-protein kinase;
DE            EC=2.7.11.1;
DE   AltName: Full=SNF1-related kinase;
GN   Name=SNRK {ECO:0000312|EMBL:AAH71567.1};
GN   Synonyms=KIAA0096 {ECO:0000312|EMBL:BAA07744.2}, SNFRK
GN   {ECO:0000312|EMBL:AAF86944.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   AUTOPHOSPHORYLATION.
RX   PubMed=12234663; DOI=10.1016/s0378-1119(02)00829-6;
RA   Kertesz N., Samson J., Debacker C., Wu H., Labastie M.-C.;
RT   "Cloning and characterization of human and mouse SNRK sucrose non-
RT   fermenting protein (SNF-1)-related kinases.";
RL   Gene 294:13-24(2002).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, ACTIVITY REGULATION, PHOSPHORYLATION
RP   AT THR-173, AND MUTAGENESIS OF THR-173.
RX   PubMed=15733851; DOI=10.1016/j.febslet.2005.01.042;
RA   Jaleel M., McBride A., Lizcano J.M., Deak M., Toth R., Morrice N.A.,
RA   Alessi D.R.;
RT   "Identification of the sucrose non-fermenting related kinase SNRK, as a
RT   novel LKB1 substrate.";
RL   FEBS Lett. 579:1417-1423(2005).
RN   [3] {ECO:0000305, ECO:0000312|EMBL:BAA07744.2}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow {ECO:0000305};
RX   PubMed=7788527; DOI=10.1093/dnares/2.1.37;
RA   Nagase T., Miyajima N., Tanaka A., Sazuka T., Seki N., Sato S., Tabata S.,
RA   Ishikawa K., Kawarabayasi Y., Kotani H., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. III. The
RT   coding sequences of 40 new genes (KIAA0081-KIAA0120) deduced by analysis of
RT   cDNA clones from human cell line KG-1.";
RL   DNA Res. 2:37-43(1995).
RN   [4] {ECO:0000305}
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5] {ECO:0000305, ECO:0000312|EMBL:AAF86944.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Adrenal gland {ECO:0000312|EMBL:AAF86944.1};
RA   Li Y., Wu T., Xu S., Ren S., Chen Z., Han Z.;
RL   Submitted (JAN-2000) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000305, ECO:0000312|EMBL:BAA91023.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Colon mucosa {ECO:0000312|EMBL:BAA91023.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8] {ECO:0000305, ECO:0000312|EMBL:AAF86944.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9] {ECO:0000305, ECO:0000312|EMBL:AAH71567.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain {ECO:0000312|EMBL:AAH71567.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10] {ECO:0000305}
RP   TISSUE SPECIFICITY.
RX   PubMed=8654423; DOI=10.1111/j.1432-1033.1996.00736.x;
RA   Becker W., Heukelbach J., Kentrup H., Joost H.G.;
RT   "Molecular cloning and characterization of a novel mammalian protein kinase
RT   harboring a homology domain that defines a subfamily of serine/threonine
RT   kinases.";
RL   Eur. J. Biochem. 235:736-743(1996).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-390, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518 AND SER-607, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-260; SER-391; SER-611; LEU-748 AND
RP   MET-765.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: May play a role in hematopoietic cell proliferation or
CC       differentiation. Potential mediator of neuronal apoptosis.
CC       {ECO:0000250|UniProtKB:Q63553, ECO:0000269|PubMed:12234663,
CC       ECO:0000269|PubMed:15733851}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:12234663, ECO:0000269|PubMed:15733851};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:12234663,
CC         ECO:0000269|PubMed:15733851};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000269|PubMed:12234663, ECO:0000269|PubMed:15733851};
CC   -!- ACTIVITY REGULATION: Activated by phosphorylation on Thr-173.
CC       {ECO:0000269|PubMed:15733851}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1 {ECO:0000269|PubMed:12234663, ECO:0000269|PubMed:15489334,
CC       ECO:0000269|PubMed:7788527};
CC         IsoId=Q9NRH2-1; Sequence=Displayed;
CC       Name=2 {ECO:0000269|PubMed:14702039};
CC         IsoId=Q9NRH2-2; Sequence=VSP_051959, VSP_051960;
CC   -!- TISSUE SPECIFICITY: Expressed in hematopoietic progenitor cells and
CC       leukemic cell lines. Weakly expressed in the testis.
CC       {ECO:0000269|PubMed:12234663, ECO:0000269|PubMed:8654423}.
CC   -!- PTM: Autophosphorylated. Phosphorylation on Thr-173 by STK11/LKB1 in
CC       complex with STE20-related adapter-alpha (STRADA) pseudo kinase and
CC       CAB39. {ECO:0000269|PubMed:15733851}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA07744.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC       Sequence=CAH18415.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D43636; BAA07744.2; ALT_INIT; mRNA.
DR   EMBL; AF226044; AAF86944.1; -; mRNA.
DR   EMBL; AK000231; BAA91023.1; -; mRNA.
DR   EMBL; AK314376; BAG37003.1; -; mRNA.
DR   EMBL; CR749621; CAH18415.1; ALT_INIT; mRNA.
DR   EMBL; CH471055; EAW64693.1; -; Genomic_DNA.
DR   EMBL; BC071567; AAH71567.1; -; mRNA.
DR   CCDS; CCDS43075.1; -. [Q9NRH2-1]
DR   RefSeq; NP_001094064.1; NM_001100594.1. [Q9NRH2-1]
DR   RefSeq; NP_001317679.1; NM_001330750.1.
DR   RefSeq; NP_060189.3; NM_017719.4. [Q9NRH2-1]
DR   RefSeq; XP_005265302.1; XM_005265245.3. [Q9NRH2-1]
DR   PDB; 5YKS; X-ray; 2.90 A; A/B=1-356.
DR   PDBsum; 5YKS; -.
DR   AlphaFoldDB; Q9NRH2; -.
DR   SMR; Q9NRH2; -.
DR   BioGRID; 120211; 15.
DR   IntAct; Q9NRH2; 20.
DR   MINT; Q9NRH2; -.
DR   STRING; 9606.ENSP00000296088; -.
DR   BindingDB; Q9NRH2; -.
DR   ChEMBL; CHEMBL1908384; -.
DR   DrugBank; DB12010; Fostamatinib.
DR   DrugCentral; Q9NRH2; -.
DR   iPTMnet; Q9NRH2; -.
DR   PhosphoSitePlus; Q9NRH2; -.
DR   BioMuta; SNRK; -.
DR   DMDM; 90185235; -.
DR   EPD; Q9NRH2; -.
DR   jPOST; Q9NRH2; -.
DR   MassIVE; Q9NRH2; -.
DR   MaxQB; Q9NRH2; -.
DR   PaxDb; Q9NRH2; -.
DR   PeptideAtlas; Q9NRH2; -.
DR   PRIDE; Q9NRH2; -.
DR   ProteomicsDB; 82362; -. [Q9NRH2-1]
DR   ProteomicsDB; 82363; -. [Q9NRH2-2]
DR   Antibodypedia; 29346; 156 antibodies from 28 providers.
DR   DNASU; 54861; -.
DR   Ensembl; ENST00000296088.12; ENSP00000296088.7; ENSG00000163788.14. [Q9NRH2-1]
DR   Ensembl; ENST00000429705.6; ENSP00000411375.2; ENSG00000163788.14. [Q9NRH2-1]
DR   Ensembl; ENST00000454177.5; ENSP00000401246.1; ENSG00000163788.14. [Q9NRH2-1]
DR   GeneID; 54861; -.
DR   KEGG; hsa:54861; -.
DR   MANE-Select; ENST00000296088.12; ENSP00000296088.7; NM_017719.5; NP_060189.3.
DR   UCSC; uc003cms.5; human. [Q9NRH2-1]
DR   CTD; 54861; -.
DR   DisGeNET; 54861; -.
DR   GeneCards; SNRK; -.
DR   HGNC; HGNC:30598; SNRK.
DR   HPA; ENSG00000163788; Low tissue specificity.
DR   MIM; 612760; gene.
DR   neXtProt; NX_Q9NRH2; -.
DR   OpenTargets; ENSG00000163788; -.
DR   PharmGKB; PA142670894; -.
DR   VEuPathDB; HostDB:ENSG00000163788; -.
DR   eggNOG; KOG4717; Eukaryota.
DR   GeneTree; ENSGT00940000155365; -.
DR   HOGENOM; CLU_007233_3_0_1; -.
DR   InParanoid; Q9NRH2; -.
DR   OMA; VGSIKFF; -.
DR   OrthoDB; 1127668at2759; -.
DR   PhylomeDB; Q9NRH2; -.
DR   TreeFam; TF351991; -.
DR   PathwayCommons; Q9NRH2; -.
DR   SignaLink; Q9NRH2; -.
DR   SIGNOR; Q9NRH2; -.
DR   BioGRID-ORCS; 54861; 10 hits in 1124 CRISPR screens.
DR   ChiTaRS; SNRK; human.
DR   GeneWiki; SNRK; -.
DR   GenomeRNAi; 54861; -.
DR   Pharos; Q9NRH2; Tchem.
DR   PRO; PR:Q9NRH2; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q9NRH2; protein.
DR   Bgee; ENSG00000163788; Expressed in pericardium and 215 other tissues.
DR   ExpressionAtlas; Q9NRH2; baseline and differential.
DR   Genevisible; Q9NRH2; HS.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0000287; F:magnesium ion binding; IDA:UniProtKB.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:UniProtKB.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR015940; UBA.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS50030; UBA; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Kinase; Magnesium;
KW   Metal-binding; Methylation; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase.
FT   CHAIN           1..765
FT                   /note="SNF-related serine/threonine-protein kinase"
FT                   /evidence="ECO:0000305"
FT                   /id="PRO_0000225605"
FT   DOMAIN          16..269
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          291..334
FT                   /note="UBA"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00212"
FT   REGION          512..634
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        544..564
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        581..634
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        139
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:P57059,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159, ECO:0000255|PROSITE-
FT                   ProRule:PRU10027"
FT   BINDING         22..30
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P57059,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         45
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:P57059,
FT                   ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDU5"
FT   MOD_RES         173
FT                   /note="Phosphothreonine; by LKB1"
FT                   /evidence="ECO:0000269|PubMed:15733851"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDU5"
FT   MOD_RES         390
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332"
FT   MOD_RES         482
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDU5"
FT   MOD_RES         495
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q63553"
FT   MOD_RES         518
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         534
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDU5"
FT   MOD_RES         607
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         244
FT                   /note="D -> E (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051959"
FT   VAR_SEQ         245..765
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_051960"
FT   VARIANT         260
FT                   /note="L -> S (in dbSNP:rs35624204)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041096"
FT   VARIANT         391
FT                   /note="P -> S (in dbSNP:rs56104180)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041097"
FT   VARIANT         611
FT                   /note="G -> S (in an ovarian mucinous carcinoma sample;
FT                   somatic mutation; dbSNP:rs368877591)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041098"
FT   VARIANT         748
FT                   /note="P -> L (in an ovarian serous carcinoma sample;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041099"
FT   VARIANT         765
FT                   /note="I -> M (in a breast pleomorphic lobular carcinoma
FT                   sample; somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_041100"
FT   MUTAGEN         173
FT                   /note="T->A,E: Prevents phosphorylation and activation by
FT                   STK11/LKB1 complex."
FT                   /evidence="ECO:0000269|PubMed:15733851"
FT   CONFLICT        97
FT                   /note="G -> E (in Ref. 5; AAF86944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        116
FT                   /note="A -> P (in Ref. 5; AAF86944)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        124
FT                   /note="V -> A (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        181
FT                   /note="S -> P (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        196
FT                   /note="V -> A (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="G -> E (in Ref. 6; BAA91023)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        219
FT                   /note="N -> D (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="S -> Y (in Ref. 9; AAH71567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="V -> A (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        482
FT                   /note="S -> G (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        486
FT                   /note="L -> V (in Ref. 9; AAH71567)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        636
FT                   /note="A -> V (in Ref. 7; CAH18415)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        722
FT                   /note="K -> R (in Ref. 9; AAH71567)"
FT                   /evidence="ECO:0000305"
FT   STRAND          26..33
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   STRAND          36..52
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           54..67
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   STRAND          78..83
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   STRAND          85..92
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           100..105
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           113..132
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           142..144
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   STRAND          145..148
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   TURN            149..152
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   STRAND          153..156
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   TURN            162..164
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           183..187
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           193..210
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           220..229
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           240..249
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   TURN            254..256
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           260..265
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           267..269
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           284..286
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           292..304
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           310..319
FT                   /evidence="ECO:0007829|PDB:5YKS"
FT   HELIX           324..343
FT                   /evidence="ECO:0007829|PDB:5YKS"
SQ   SEQUENCE   765 AA;  84276 MW;  06EF88CF7F8A393D CRC64;
     MAGFKRGYDG KIAGLYDLDK TLGRGHFAVV KLARHVFTGE KVAVKVIDKT KLDTLATGHL
     FQEVRCMKLV QHPNIVRLYE VIDTQTKLYL ILELGDGGDM FDYIMKHEEG LNEDLAKKYF
     AQIVHAISYC HKLHVVHRDL KPENVVFFEK QGLVKLTDFG FSNKFQPGKK LTTSCGSLAY
     SAPEILLGDE YDAPAVDIWS LGVILFMLVC GQPPFQEAND SETLTMIMDC KYTVPSHVSK
     ECKDLITRML QRDPKRRASL EEIENHPWLQ GVDPSPATKY NIPLVSYKNL SEEEHNSIIQ
     RMVLGDIADR DAIVEALETN RYNHITATYF LLAERILREK QEKEIQTRSA SPSNIKAQFR
     QSWPTKIDVP QDLEDDLTAT PLSHATVPQS PARAADSVLN GHRSKGLCDS AKKDDLPELA
     GPALSTVPPA SLKPTASGRK CLFRVEEDEE EDEEDKKPMS LSTQVVLRRK PSVTNRLTSR
     KSAPVLNQIF EEGESDDEFD MDENLPPKLS RLKMNIASPG TVHKRYHRRK SQGRGSSCSS
     SETSDDDSES RRRLDKDSGF TYSWHRRDSS EGPPGSEGDG GGQSKPSNAS GGVDKASPSE
     NNAGGGSPSS GSGGNPTNTS GTTRRCAGPS NSMQLASRSA GELVESLKLM SLCLGSQLHG
     STKYIIDPQN GLSFSSVKVQ EKSTWKMCIS STGNAGQVPA VGGIKFFSDH MADTTTELER
     IKSKNLKNNV LQLPLCEKTI SVNIQRNPKE GLLCASSPAS CCHVI
//
